- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03840863
Effects of Chronic Energy Drink Consumption on Cardiometabolic Endpoints
Many people use energy drinks (EDs) regularly, but the overall health concerns are still unknown. There are many energy drink products that contain a mixture of caffeine and other energy-boosting ingredients and supplements which can affect parameters related to the heart, blood pressure and blood glucose. Several previous studies have shown that energy drinks may affect heart rhythm and blood pressure significantly. As energy drinks are sugar-sweetened beverages, long-term use may also affect the body's metabolism, including cholesterol, blood sugars, and weight.
The purpose of this study is to learn if drinking energy drinks everyday may affect a person's cardiometabolic health.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The popularity of energy drinks (EDs) have increased over the last few decades due to their purported benefits as mental and physical performance enhancements. While caffeine is a major ingredient in most EDs (ranging from 80 mg to 500 mg per drink), they may also contain various supplements, such as guarana, taurine, ginseng, B vitamins, gluconolactone, yohimbe, carnitine, and bitter orange, as well as high amount of sugar (ranging from 25-50 grams). The United States Food and Drug Administration (FDA) has cited that a daily intake of 400 mg caffeine (approximately 4-5 cups of coffee) in adults is generally safe and not associated with dangerous, negative effects. The Substance Abuse and Mental Health Services Administration reported a doubling of emergency department visits involving EDs from 10,068 visits in 2007 to 20,783 visits in 2011. Commonly reported adverse reactions include insomnia, nervousness, headache, tachycardia, and seizures. Currently, the health effects of long-term ED use remain unknown.
This study is a proof-of-concept, prospective trial that aims to evaluate the effects of chronic ED consumption on cardiometabolic parameters in a healthy population. Subjects will consume two cans (16 oz.) of an energy drink daily for 4 weeks. The study will assess any changes in blood pressure (BP), electrocardiographic (ECG) parameters, blood glucose, cholesterol, weight, body mass index (BMI), and body fat composition before and after consuming EDs for 4 weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stockton, California, United States, 95211
- University of the Pacific
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy adults aged 18 - 40 years
- Participants willing to adhere to study drink schedule (28 days)
Exclusion Criteria:
- Naïve caffeine consumers (< 2 cups of coffee [or equivalent caffeine intake] per week)
- Chronic medical conditions including cardiovascular disease (known history of cardiac arrhythmias, family history of premature sudden cardiac death before age 60, cardiomyopathy, atherosclerosis), smoking, renal or hepatic dysfunction
- Prolonged corrected QT (QTc) interval
- History of substance abuse, including alcohol
- Concurrent use of prescription drugs or over-the-counter products that may interact with study drinks (with the exception of oral contraceptives that have been used for over 1 month)
- Baseline Blood Pressure greater than 140/90 mmHg
- Baseline fasting blood glucose greater than 126 mg/dL or random blood glucose greater than 200 mg/dL
- Females only: pregnancy or lactation, or planning to get pregnant within next 28 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Commercially-Available Energy drink
Healthy volunteers willing to consume two cans of energy drinks (16 oz./can) daily for 4 weeks
|
Participant will consume 2 cans of an energy drink (16 oz./can) per day.
One in the morning and one in the afternoon.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in blood pressure before and 1 hour after energy drink consumption
Time Frame: 1 hour
|
Measuring acute changes in peripheral systolic blood pressure before and 1 hour after energy drink consumption
|
1 hour
|
|
Change in blood pressure before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring chronic changes in peripheral systolic blood pressure before and 4 weeks after energy drink consumption
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in QTc Interval before and after 1 hour of energy drink consumption
Time Frame: 1 hour
|
Measuring change in QTc interval via electrocardiogram before and after 1 hour of energy drink consumption
|
1 hour
|
|
Change in QTc Interval before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring change in QTc interval via electrocardiogram before and after 4 weeks of energy drink consumption
|
4 weeks
|
|
Change in fasting blood glucose before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring the change in fasting blood glucose before and after 4 weeks of energy drink consumption
|
4 weeks
|
|
Change in fasting lipid panel parameters before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring the changes in total cholesterol (TC), high-density lipoprotein (HDL), triglyceride (TG), and calculated low-density lipoprotein (LDL-C) levels before and after 4 weeks of energy drink consumption
|
4 weeks
|
|
Change in Body Mass Index before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring the change in Body Mass Index (BMI) before and after 4 weeks of energy drink consumption
|
4 weeks
|
|
Change in Body Fat Analysis before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring the changes in Body Fat Analysis before and after 4 weeks of energy drink consumption, including percentage of body fat, fat mass, muscle mass, and fat in trunk
|
4 weeks
|
|
Change in Serum Creatinine before and after 4 weeks of energy drink consumption
Time Frame: 4 weeks
|
Measuring the change in Serum Creatinine before and after 4 weeks of energy drink consumption
|
4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: May Chen, PharmD, University of the Pacific
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Commercially-Available Energy Drink
-
Anglia Ruskin UniversityDanone Global Research & Innovation CenterCompleted
-
University of Colorado, DenverColorado State University; Institute of Cannabis Research, Colorado State University...CompletedAlcohol Use Disorder | Cannabis UseUnited States
-
AtriCure, Inc.RecruitingPostural Tachycardia Syndrome | Inappropriate Sinus TachycardiaUnited States, Belgium
-
MedtronicNeuroTerminatedPain, Chronic | Pain, IntractableUnited States
-
Massachusetts Institute of TechnologyHanger Clinic: Prosthetics & OrthoticsRecruitingAmputation of Lower Limb Below KneeUnited States
-
Massachusetts General HospitalHarvard School of Public Health (HSPH)Completed
-
Universitair Ziekenhuis BrusselCompletedInfertility, FemaleBelgium
-
Direct Flow Medical, Inc.UnknownAortic Valve StenosisUnited States
-
MedtronicRecruitingChronic Pain | Intractable PainUnited States